DAILYZ HEALTH NEWS

June 3, 2026 Evan Vega

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.

Health

June 2, 2026 Evan Vega

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.

Health

June 2, 2026 Evan Vega

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.

Health

June 2, 2026 Evan Vega

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe

UnitedHealth’s Change Healthcare unit suffered a ransomware attack exposing data of 4.2 million patients; a $22 million ransom was paid.

Health

May 29, 2026 Evan Vega

New study links routine blood test marker changes to earlier detection of aggressive cancer

A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.

Health

May 29, 2026 Evan Vega

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

The WHO launched clinical trials for Bundibugyo virus Ebola treatments and vaccines following outbreaks in the DRC and Uganda.

Health

May 29, 2026 Evan Vega

Cochrane review finds PSA screening likely reduces prostate cancer deaths

A Cochrane review of six trials found PSA screening likely reduces prostate cancer deaths by about two per 1,000 men screened.

Health

May 29, 2026 Evan Vega

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

CDC confirms first U.S. human H5N1 bird flu case linked to exposure to infected dairy cattle in a Texas farm worker.

Health

May 29, 2026 Evan Vega

CMS Proposes 3.1% Payment Increase for U.S. Hospitals in 2027 While Expanding Value-Based Quality Reporting Requirements

CMS proposes a 3.1% payment increase for U.S. hospitals in 2027 and expands value-based quality reporting requirements.

Health

May 29, 2026 Evan Vega

FDA Warns Online Pharmacies Selling Counterfeit Semaglutide Weight-Loss Injections After Cluster of Severe Adverse Events

The FDA warns against counterfeit semaglutide injections sold online after severe adverse events linked to fake Ozempic products.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

CMS Proposes 3.1% Payment Increase for U.S. Hospitals in 2027 While Expanding Value-Based Quality Reporting Requirements

FDA Warns Online Pharmacies Selling Counterfeit Semaglutide Weight-Loss Injections After Cluster of Severe Adverse Events